← Back
Data updated: Mar 10, 2026
NORVIUM BIOSCIENCE
Pharmaceuticals
NORVIUM BIOSCIENCE is a specialty pharmaceutical company with 5 FDA-approved products.
1958
Since
5
Drugs
-
Trials
22
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
SUMATRIPTAN SUCCINATE 2025-11-06
SUMATRIPTAN SUCCINATE 2025-10-21
Labeling
TRIAMCINOLONE ACETONIDE 2025-10-17
TRIAMCINOLONE ACETONIDE 2025-10-08
Labeling
SUMATRIPTAN SUCCINATE 2025-07-25
Labeling
SUMATRIPTAN SUCCINATE 2025-07-15
TRIAMCINOLONE ACETONIDE 2025-04-11
TRIAMCINOLONE ACETONIDE 2025-04-03
Labeling
SUMATRIPTAN SUCCINATE 2025-03-28
Manufacturing (CMC)
SUMATRIPTAN SUCCINATE 2025-03-17
Manufacturing (CMC)
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (4)
Company Info
- First Approval
- 1958-05-05
- Latest
- 2022-05-18
- Applications
- 5